Star Health and Allied Insurance Company Limited (STARHEALTH)
₹548.85 -0.21% last close, 16 Oct
Q2 FY27 results
📅 Next results: 27 Oct 2026 (board meeting)Star Health and Allied Insurance Company Limited's board meets on 27 Oct 2026 to consider its Q2 FY27 results (July-September 2026).
In its latest reported quarter, Q1 FY27, Star Health's revenue was ₹4,917 Cr (+16.2% year on year, +5.8% on the previous quarter), and net profit ₹550 Cr (+109.0% year on year); the operating margin was 8.6%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹4,917 | +16.2% | +5.8% |
| Operating profit | ₹425 | +21.1% | +187.2% |
| Net profit | ₹550 | +109.0% | +395.3% |
| EPS (₹) | 9.34 | +108.9% | +394.2% |
| Operating margin | 8.6% | — | — |
STARHEALTH delivery percentage and bulk deals
NSE end-of-day data for
On Fri, 16 Oct 2026, 62.95% of the STARHEALTH shares traded on NSE were taken to delivery, against the stock's own 20-session average of 58.79%. That is close to its usual level. Volume was 0.2 times its average, well below normal. 2 bulk or block deals were reported in STARHEALTH in the last 60 days: ₹457 Cr bought and ₹457 Cr sold.
Delivery in the last 5 sessions: 62.4% · 52.1% · 60.0% · 54.5% · 63.0%
| Date | Side | Counterparty | Value | Price | Quantity | Type |
|---|---|---|---|---|---|---|
| 24 Sep | Buy | Sbi Mutual Fund | ₹456.76 Cr | ₹550.40 | 8,298,710 | Bulk |
| 24 Sep | Sell | Sbi Mutual Fund | ₹456.75 Cr | ₹550.40 | 8,298,434 | Bulk |
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Star Health and Allied Insurance announced that India Ratings and Research Private Limited has reaffirmed its issuer rating at 'AA+' with a Stable outlook on September 28, 2026. Concurrently, the rating agency affirmed the rating of 'AA' with a Stable outlook for the company's subordinate debt. Star Health carries modest debt of ₹490 Cr against a net worth of ₹9,578 Cr (D/E of 0.05). The reaffirmation indicates sustained credit profile and capital adequacy across its operations.
- India Ratings reaffirmed existing issuer rating at AA+ with a Stable outlook
- Subordinated debt rating affirmed at AA with a Stable outlook
- Agency disclosure published on September 28, 2026, and notified to exchanges on October 01, 2026
- Company carries total debt of ₹490 Cr against ₹9,578 Cr net worth (D/E: 0.05)
Star Health and Allied Insurance Company has formally submitted an application to the stock exchanges (BSE and NSE) seeking withdrawal of the reclassification application for certain promoter group entities. Following this, Industrial Glass Fiber Industries and Interics will cease to form part of the Promoter Group with immediate effect. Meanwhile, IDC Electronics Limited will continue to remain part of the Promoter Group. The filing represents an administrative update under Regulation 31A(8)(c) of SEBI LODR Regulations.
- Application filed under Regulation 31A(8)(c) of SEBI LODR Regulations on September 17, 2026
- Withdrawal applies to 3 entities: Industrial Glass Fiber Industries, Interics, and IDC Electronics Limited
- Industrial Glass Fiber Industries and Interics cease to be Promoter Group entities with immediate effect
- IDC Electronics Limited continues to remain part of the Promoter Group
- Follows previous company board approvals dated September 11, 2026, and September 16, 2026
Star Health and Allied Insurance Company Limited has informed the exchanges about a scheduled one-on-one institutional investor meeting with Nomura Asset Management. The in-person meeting will take place in Mumbai on Tuesday, September 22, 2026, from 11:30 AM to 12:30 PM. The company noted that the presentation is publicly available via a Cloudfront URL, with no unpublished price-sensitive information expected to be discussed. This is a routine institutional interaction for the ₹32,314 Cr market cap insurer.
- One-on-one meeting scheduled with Nomura Asset Management
- Meeting date: Tuesday, September 22, 2026
- Time window: 11:30 A.M to 12:30 P.M in Mumbai (In-person)
- Investor presentation link shared as per SEBI LODR Regulation 30
Star Health and Allied Insurance Company Limited has informed the exchanges about a scheduled one-on-one meeting with institutional investor Nomura Asset Management. The in-person meeting will take place in Mumbai on September 22, 2026, from 11:30 AM to 12:30 PM. The company stated that a presentation link has been provided and standard publicly available materials will be referenced. As a routine statutory disclosure under SEBI LODR Regulation 30, it involves no immediate operational or financial change.
- One-on-one in-person meeting scheduled with Nomura Asset Management
- Meeting date: Tuesday, September 22, 2026, from 11:30 AM to 12:30 PM
- Location: Mumbai, under SEBI LODR Regulation 30 requirements
Star Health and Allied Insurance Company has approved the withdrawal of its application to reclassify three entities from the 'Promoter/Promoter Group' category to 'Public'. The entities involved are IDC Electronics Limited, Interics, and Industrial Glass Fiber Industries. The approval was granted via a circular resolution passed by the Board of Directors on September 16, 2026, pursuant to SEBI Listing Regulations (Regulation 31A). As of June 2026, total promoter holding stood at 58.01%, and this administrative decision maintains their current classification.
- Board approved withdrawal of reclassification application for 3 Promoter Group entities on September 16, 2026
- Entities involved comprise Industrial Glass Fiber Industries, Interics, and IDC Electronics Limited
- Approval granted under Regulation 31A of SEBI LODR Regulations by requisite majority via circular resolution initiated on September 15, 2026
- Withdrawal follows earlier company intimation dated September 11, 2026
Star Health and Allied Insurance Company Limited has notified the exchanges regarding its scheduled participation in the JP Morgan India Conference. The in-person group meeting with analysts and institutional investors will take place in Mumbai on September 21, 2026, starting from 10:00 AM onwards. The company has shared a web link to its investor presentation. This is a routine institutional interaction intimation with no financial or operational impact.
- Participation in JP Morgan India Conference scheduled for September 21, 2026
- In-person group interaction taking place in Mumbai from 10:00 AM onwards
- Investor presentation link disclosed under SEBI LODR Regulation 30
Star Health and Allied Insurance Company Limited announced its schedule for one-on-one institutional investor meetings at the JP Morgan India Conference. The meetings will take place in-person on Monday, September 21, 2026, starting at 10:00 A.M. onwards in Mumbai. The company noted that the schedule remains subject to changes and provided a link to the presentation materials.
- One-to-one institutional meetings scheduled for September 21, 2026
- Participation at the JP Morgan India Conference in Mumbai
- Session starts from 10:00 A.M. onwards in-person mode
- Investor presentation link shared per SEBI LODR Regulation 30
Star Health and Allied Insurance has notified stock exchanges regarding the withdrawal of its application for reclassification of promoter group entities submitted on August 14, 2026. The company stated that Industrial Glass Fiber Industries and Interics were wound up effective March 31, 2024, and have ceased to exist, automatically removing them from the promoter group. Concurrently, the company received a request from promoters to withdraw the reclassification application for IDC Electronics Limited, subject to Board approval. This filing is administrative in nature and has no impact on the company's core operations or financials.
- Withdrawal of promoter reclassification application originally submitted on August 14, 2026
- Industrial Glass Fiber Industries and Interics wound up effective March 31, 2024, ceasing to exist
- IDC Electronics Limited reclassification application to be withdrawn following promoter request
- Withdrawal process remains subject to the approval of the Board of Directors
Star Health and Allied Insurance Company has scheduled a virtual one-to-one investor meeting with Ellerston Capital on Wednesday, September 16, 2026, from 10:30 A.M. to 11:30 A.M. The company noted that the intimation is being provided at shorter notice due to investor exigencies. A link to the corporate investor presentation was made available in the filing. This is a routine institutional interaction and entails no material financial impact.
- One-to-one virtual meeting scheduled with Ellerston Capital
- Meeting date: Wednesday, September 16, 2026
- Time slot: 10:30 A.M. to 11:30 A.M. IST
- Notice issued at short notice due to investor exigencies
Star Health and Allied Insurance Company has scheduled a virtual one-on-one meeting with institutional investor Ellerston Capital on September 16, 2026, from 10:30 AM to 11:30 AM. The company noted that the intimation was given at shorter notice due to business exigencies on the investor's end. The meeting presentation link has been made available via an exchange disclosure. No unpublished price-sensitive information or material operational decisions were disclosed.
- One-on-one virtual meeting scheduled with Ellerston Capital
- Meeting date set for Wednesday, September 16, 2026
- Time allocated is 10:30 A.M. to 11:30 A.M.
- Presentation link shared publicly as per SEBI Regulation 30
Star Health and Allied Insurance Company has scheduled a virtual one-on-one meeting with Ellerston Capital for September 16, 2026, from 10:30 AM to 11:30 AM. The company noted that the intimation was provided at short notice due to investor exigencies. A link to the investor presentation was also provided as part of the disclosure under SEBI LODR Regulation 30. No new operational or financial numbers were disclosed in this routine intimation.
- One-on-one virtual meeting scheduled with Ellerston Capital
- Meeting date set for September 16, 2026, from 10:30 A.M. to 11:30 A.M.
- Intimated at shorter notice due to business exigencies on the part of the investor
- Investor presentation link included in the regulatory disclosure
Star Health and Allied Insurance Company has scheduled a virtual one-to-one meeting with institutional investor Ellerston Capital on September 16, 2026, between 10:30 AM and 11:30 AM IST. The company noted that the intimation was made at shorter notice due to investor exigencies and has provided a web link to its presentation. This is a procedural disclosure under Regulation 30 of SEBI LODR Regulations without any material operational or financial developments reported.
- Virtual one-to-one meeting scheduled with Ellerston Capital
- Meeting set for September 16, 2026, from 10:30 A.M. to 11:30 A.M. IST
- Intimation issued on September 11, 2026, at shorter notice due to investor exigencies
- Investor presentation link shared publicly via cloudfront
Star Health and Allied Insurance Company Limited declared the voting results of its 21st Annual General Meeting held on August 28, 2026. Shareholders approved all three tabled resolutions, including the adoption of audited Standalone Financial Statements for FY26 with 99.9999% votes in favour. Additionally, the re-appointment of Director Deepak Ramineedi (99.59% in favour) and appointment of Utpal Hemendra Sheth as Nominee Director representing Sitara Partners LLP (97.61% in favour) were approved. Out of 171,576 eligible shareholders on the August 21, 2026 record date, overall voting turnout reached 89.14% for the director resolutions.
- Adoption of FY26 standalone financial statements approved with 99.9999% votes in favour (498,697,960 votes)
- Appointment of Utpal Hemendra Sheth as Nominee Director for Sitara Partners LLP passed with 97.6100% approval
- Re-appointment of Director Deepak Ramineedi passed with 99.5871% approval
- Total voter turnout stood at 89.1414% across 524,707,522 polled votes for director appointments
- Total registered shareholders on record date (August 21, 2026) stood at 171,576
Star Health and Allied Insurance Company Limited has released the Scrutinizer's Report for its 21st Annual General Meeting held on August 28, 2026. All three tabled resolutions were passed by shareholders with overwhelming majorities. Adoption of the FY26 audited financial statements was approved with 99.9999% favourable votes. Shareholders also approved the re-appointment of Director Deepak Ramineedi (99.59% in favour) and the appointment of Utpal Hemendra Sheth as Nominee Director representing Sitara Partners LLP (97.61% in favour).
- Adoption of FY26 Audited Standalone Financial Statements approved with 99.9999% votes in favour (498,697,960 votes).
- Re-appointment of Director Deepak Ramineedi approved with 99.5871% votes in favour (522,541,253 votes).
- Appointment of Utpal Hemendra Sheth as Nominee Director of Sitara Partners LLP passed as a Special Resolution with 97.61% votes in favour (512,167,069 votes).
- Remote e-voting was held from August 25 to August 27, 2026, with an eligibility cut-off date of August 21, 2026.
Star Health and Allied Insurance Company Limited announced that its shareholders have approved the appointment of Mr. Utpal Hemendra Sheth as a Non-Executive Nominee Director representing Sitara Partners LLP, effective August 28, 2026. Mr. Sheth brings over 35 years of financial markets and investment management experience, having previously served as CEO and Senior Partner at Rare Enterprises. The appointment is non-rotational and follows shareholder approval via a Special Resolution.
- Shareholders approved the appointment of Mr. Utpal Hemendra Sheth (DIN: 00081012) via Special Resolution
- Appointment effective date is August 28, 2026, as a Non-Executive Nominee Director representing Sitara Partners LLP
- Mr. Sheth is not liable to retire by rotation and has over 35 years of industry experience across investment management and corporate finance
Financial Performance
Revenue Growth by Segment
Retail Health GWP grew 17% YoY to INR 8,332 Cr in H1 FY2026, driven by 24% growth in fresh retail premiums. In FY2025, the Agency channel contributed 82% of GWP with 16% YoY fresh business growth, while Digital grew 71% in fresh business, Banca grew 13%, and MSME grew 21%.
Geographic Revenue Split
The company operates across 25 states and 5 Union Territories, covering 724 out of 19,101 PIN codes. It maintains a branch network 3x larger than its nearest private competitor with 913 branches.
Profitability Margins
Profit After Tax (PAT) for FY2025 was INR 787 Cr, down from INR 1,103 Cr in FY2024. Return on Equity (ROE) stood at 9.5%. The combined ratio under IND AS was 101.1% in FY2025 compared to 97.3% in FY2024.
EBITDA Margin
Underwriting profitability was impacted by a claims ratio of 70.7% in FY2025 (up from 70.3% in FY2024). Expense of Management (EOM) was 30.7% in FY2024, providing operational flexibility below the 35% regulatory cap.
Capital Expenditure
Not explicitly disclosed in INR Cr, but the company added 74,000 new agents in FY2025 and expanded its home healthcare services to 156 cities.
Credit Rating & Borrowing
Maintains comfortable solvency at 2.21x as of March 2025, well above the 1.5x regulatory requirement. Solvency is supported by INR 470 Cr of subordinate debt.
Operational Drivers
Raw Materials
Claims Outgo (70.7% of GWP), Commission/Brokerage, and Operating Expenses (30.4% Expense Ratio).
Import Sources
Not applicable for insurance services; sourcing refers to domestic healthcare provider networks.
Key Suppliers
Network of 14,203 hospitals as of March 31, 2023, with 67% of claims paid via Agreed Network Hospitals (ANH).
Capacity Expansion
Current agent count is 7.75 lakhs, with a planned expansion to 1 million agents over the next three years to deepen penetration in non-metro cities.
Raw Material Costs
Claims ratio increased to 70.7% in FY2025 due to higher frequency and severity of hospitalizations. Proprietary AIML fraud detection delivered 35% savings growth in claims outgo.
Manufacturing Efficiency
96% of cashless claims processed within 3 hours; claim rejection rate reduced from 13% to 10% in FY2025.
Logistics & Distribution
Agency channel is the cornerstone, contributing 82% of GWP. Digital segment accounts for 8% of total business.
Strategic Growth
Expected Growth Rate
16%
Growth Strategy
Recalibration of group business (reducing GWP contribution from 9% to 7%), exiting unprofitable employer-employee portfolios, and repricing 65% of the retail book. Expansion of the agent network to 1 million and focus on high sum insured policies.
Products & Services
Retail health insurance policies, MSME/SME group insurance, and specialized products like the 'Superstar' policy and India's first Braille policy for the visually impaired.
Brand Portfolio
Star Health and Allied Insurance, Superstar Policy.
New Products/Services
Superstar policy (generated INR 580 Cr GWP), Braille policy, and tailored products for Gen Z and senior citizens under the FY2026 'Year of the Customer' initiative.
Market Expansion
Deepening penetration in non-metro cities and emerging towns via the 1-million agent expansion plan and 1,000+ Sales Manager Stations.
Market Share & Ranking
Largest standalone health insurer (SAHI) in India with 44% SAHI market share and 32-33% retail health market share.
Strategic Alliances
Banca channel partnerships with over 20,000 bank branches; 7% contribution to total business.
External Factors
Industry Trends
Health insurance industry (SAHI) grew at 25% CAGR (2019-2024). Future direction involves digital-first adoption (71% fresh digital business growth) and regulatory reporting shifts to annual premiums.
Competitive Landscape
Faces competition from general insurers and other SAHI players; Star maintains leadership despite a slight market share moderation from 33% to 32%.
Competitive Moat
Dominant retail market share (33%), massive distribution network (7.75 lakh agents), and 3x branch count vs competitors create high barriers to entry and network effects.
Macro Economic Sensitivity
Healthcare inflation and rising awareness of indemnity-based products drive demand; GDP growth supports middle-class insurance adoption.
Consumer Behavior
Shift toward higher sum assured and digital-to-consumer platforms (Star's online channel contributes 72% of its digital business).
Geopolitical Risks
Minimal direct impact due to domestic focus, though global economic developments can influence investment yields (7.7% in FY2025).
Regulatory & Governance
Industry Regulations
IRDAI mandates a 1.5x solvency ratio (Star is at 2.21x). New IRDAI reporting guidelines for long-tail policies (10% of Star's premium) impacted reported growth metrics.
Environmental Compliance
Rated India's most sustainable insurer by S&P Global with an ESG score of 53.
Taxation Policy Impact
Effective tax rate implied by PBT of INR 1,054 Cr and PAT of INR 787 Cr (approx 25.3%).
Legal Contingencies
Not disclosed in available documents; internal controls are reviewed quarterly by the Audit Committee.
Risk Analysis
Key Uncertainties
Single line of business risk (health only) exposes the company to event risks like pandemics or high claims inflation (claims ratio rose to 70.7%).
Geographic Concentration Risk
Covers 25 states; however, the company is consciously curtailing growth in 'riskier geographies' to maintain underwriting profitability.
Third Party Dependencies
Dependency on 20,000 partner bank branches for the Banca channel (7% of business) and 14,203 network hospitals.
Technology Obsolescence Risk
Mitigated by digital-first strategy, 1 Cr app downloads, and proprietary AIML platforms for fraud detection.
Credit & Counterparty Risk
Receivables quality is generally high in retail insurance due to upfront premium payments; investment portfolio of INR 17,889 Cr is the primary counterparty risk area.